The Immunological Basis of Genesis of Gastrointestinal Cancer and Its Diagnostic and Therapeutic Implications
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 5371
Special Issue Editors
2. Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
3. Health, Biological & Experimental Sciences, University of Coventry, Coventry CV1 5FB, UK
4. School of Health Sciences, University of Leicester, Leicester LE1 7RH, UK
Interests: colon cancer biomarker; volatile organic compounds; bile acid pathophysiology and artificial intelligence
Special Issues, Collections and Topics in MDPI journals
Interests: general surgery; hepatobiliary & pancreatic surgery; kidney and liver transplant
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
An immunopathological understanding behind the genesis of various gastrointestinal cancers, including liver, colorectal, and pancreatic cancer, is needed. The introduction of immunomodulatory changes behind immune evasion has a substantial effect on the progression of cancer, and has brought significant changes in the diagnostic categorization and therapeutic approaches. The molecular characterization of the immune evasion mechanism has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcomes.
The rapid advancement and expansion in the knowledge of immunomodulatory changes and the reinstatement of immunity has evolved in the diagnosis and management of these cancers; hence, this Special Issue of Diagnostics intends to add to the current knowledge with key articles that critically outline the diagnosis and therapeutic challenges related to gastrointestinal cancers, notably liver, pancreatic, and colorectal. Furthermore, it will also accept articles addressing impact of Covid-19 on patients receiving immunotherapy or those who have had organ transplants.
Prof. Dr. Ramesh P. Arasaradnam
Dr. Kumar Jayant
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Hepatocellular carcinoma
- Cholangiocarcinoma
- Pancreatic carcinoma
- Neuroendocrine tumour of pancreas
- Colorectal carcinoma
- Colorectal liver metastasis
- Immunomodulation
- Checkpoint inhibitors
